SCHEMBL2964360

SCHEMBL2964360

Cc1cc(C)c(C2C=Cc3ccccc32)cc1Br

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.31
ALDH1A1 P00352 1/20 0.31
HTR6 P50406 1/20 0.30
HTR2A P28223 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2962076 0.94 SIGMAR1 (0.31) SIGMAR1ALDH1A1HTR6HTR2A
SCHEMBL2959780 0.84 CYP1A2 (0.33) ALDH1A1
SCHEMBL2960983 0.84 TDP1 (0.31) ALDH1A1
SCHEMBL2964355 0.82 ALDH1A1 (0.32) SIGMAR1ALDH1A1HTR6HTR2A
SCHEMBL2957722 0.81 ALDH1A1 (0.35) ALDH1A1
SCHEMBL27640461 0.80 SIGMAR1 (0.33) SIGMAR1HTR6HTR2A
SCHEMBL2959814 0.80 MAOA (0.31) ALDH1A1
SCHEMBL2970232 0.80 MAOA (0.31) ALDH1A1
SCHEMBL2963468 0.78 MEN1 (0.30) SIGMAR1ALDH1A1
SCHEMBL2964722 0.78 CYP2A6 (0.40) ALDH1A1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 SIGMAR1 3249/4885ALDH1A1 4332/4885HTR6 2737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.